About: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Sector: Healthcare
Industry: Medical Devices
Latest price: $149.01 (+0.60%)
PODD NASDAQ Insulet Corporation
Insulet Corporation share price
Atividade de preço de PODD
Último preço
$ 149,010
Variação (24h)
0,89 USD (0,60%)
Volume
802.69K
Volume (média 4 sem.)
-
Abertura
$ 147,87
Variação do dia
$ 145,00 - $ 149,69
Fechamento anterior
$ 148,12
Último negócio
23 Oct, 8:11 pm GMT+0
Atrasado
23 Oct, 8:11 pm GMT+0
PODD price performance
Atrasado
23 Oct, 8:11 pm GMT+0
quote.marketSignals